Phathom Pharmaceuticals Stock Price History
| PHAT Stock | USD 6.79 0.17 2.44% |
Below is the normalized historical share price chart for Phathom Pharmaceuticals extending back to October 25, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Phathom Pharmaceuticals stands at 6.79, as last reported on the 21st of January, with the highest price reaching 7.05 and the lowest price hitting 6.43 during the day.
If you're considering investing in Phathom Stock, it is important to understand the factors that can impact its price. Phathom Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.21, which implies the firm had a -0.21 % return per unit of risk over the last 3 months. Phathom Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Phathom Pharmaceuticals' Risk Adjusted Performance of (0.13), variance of 34.64, and Coefficient Of Variation of (591.00) to confirm the risk estimate we provide.
At this time, Phathom Pharmaceuticals' Issuance Of Capital Stock is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 54.4 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (62.2 M). . Price To Sales Ratio is likely to drop to 549.29 in 2025. Price Earnings Ratio is likely to drop to -2.2 in 2025. Phathom Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of October 2019 | 200 Day MA 11.9688 | 50 Day MA 9.113 | Beta 0.718 |
Phathom |
Sharpe Ratio = -0.2071
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PHAT |
Estimated Market Risk
| 5.96 actual daily | 53 53% of assets are less volatile |
Expected Return
| -1.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Phathom Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phathom Pharmaceuticals by adding Phathom Pharmaceuticals to a well-diversified portfolio.
Price Book 25.3678 | Enterprise Value Ebitda (2.20) | Price Sales 18.116 | Shares Float 55.8 M | Wall Street Target Price 24.8571 |
Phathom Pharmaceuticals Stock Price History Chart
There are several ways to analyze Phathom Stock price data. The simplest method is using a basic Phathom candlestick price chart, which shows Phathom Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 4, 2024 | 18.94 |
| Lowest Price | January 13, 2025 | 6.62 |
Phathom Pharmaceuticals January 21, 2025 Stock Price Synopsis
Various analyses of Phathom Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Phathom Stock. It can be used to describe the percentage change in the price of Phathom Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Phathom Stock.| Phathom Pharmaceuticals Price Action Indicator | (0.03) | |
| Phathom Pharmaceuticals Price Rate Of Daily Change | 0.98 | |
| Phathom Pharmaceuticals Price Daily Balance Of Power | (0.27) |
Phathom Pharmaceuticals January 21, 2025 Stock Price Analysis
Phathom Stock Price History Data
The price series of Phathom Pharmaceuticals for the period between Wed, Oct 23, 2024 and Tue, Jan 21, 2025 has a statistical range of 12.32 with a coefficient of variation of 37.65. The price distribution for the period has arithmetic mean of 10.95. The median price for the last 90 days is 8.95.| Open | High | Low | Close | Volume | ||
01/21/2025 | 6.96 | 7.05 | 6.42 | 6.79 | ||
01/21/2025 | 6.96 | 7.05 | 6.42 | 6.79 | ||
| 01/17/2025 | 6.98 | 7.05 | 6.78 | 6.96 | 754,613 | |
| 01/16/2025 | 7.15 | 7.20 | 6.74 | 6.96 | 871,494 | |
| 01/15/2025 | 6.97 | 7.15 | 6.64 | 7.13 | 743,851 | |
| 01/14/2025 | 6.68 | 6.83 | 6.42 | 6.79 | 873,633 | |
| 01/13/2025 | 6.78 | 6.90 | 6.36 | 6.62 | 1,176,393 | |
| 01/10/2025 | 6.91 | 7.11 | 6.73 | 6.94 | 995,736 | |
| 01/08/2025 | 7.12 | 7.19 | 6.82 | 6.95 | 842,751 | |
| 01/07/2025 | 7.69 | 7.78 | 7.16 | 7.20 | 841,757 | |
| 01/06/2025 | 7.74 | 7.91 | 7.55 | 7.61 | 627,072 | |
| 01/03/2025 | 7.38 | 7.79 | 7.34 | 7.74 | 816,568 | |
| 01/02/2025 | 8.18 | 8.34 | 7.33 | 7.33 | 1,014,888 | |
| 12/31/2024 | 7.99 | 8.33 | 7.85 | 8.12 | 1,009,222 | |
| 12/30/2024 | 8.16 | 8.29 | 7.80 | 8.00 | 799,617 | |
| 12/27/2024 | 8.08 | 8.22 | 7.85 | 8.18 | 848,664 | |
| 12/26/2024 | 7.51 | 8.31 | 7.40 | 8.10 | 1,119,398 | |
| 12/24/2024 | 7.59 | 7.72 | 7.21 | 7.50 | 401,705 | |
| 12/23/2024 | 7.42 | 7.65 | 7.03 | 7.61 | 950,212 | |
| 12/20/2024 | 7.71 | 7.83 | 7.39 | 7.45 | 2,475,983 | |
| 12/19/2024 | 8.00 | 8.14 | 7.80 | 7.82 | 1,225,015 | |
| 12/18/2024 | 8.34 | 8.60 | 7.78 | 7.99 | 1,031,947 | |
| 12/17/2024 | 8.08 | 8.47 | 8.02 | 8.37 | 603,683 | |
| 12/16/2024 | 8.45 | 8.56 | 8.02 | 8.14 | 1,024,121 | |
| 12/13/2024 | 7.98 | 8.25 | 7.81 | 7.89 | 1,002,333 | |
| 12/12/2024 | 8.42 | 8.47 | 7.92 | 7.99 | 1,187,395 | |
| 12/11/2024 | 8.98 | 9.10 | 7.70 | 8.40 | 1,552,417 | |
| 12/10/2024 | 9.23 | 9.62 | 8.90 | 8.93 | 806,470 | |
| 12/09/2024 | 9.10 | 9.79 | 9.08 | 9.29 | 925,641 | |
| 12/06/2024 | 8.44 | 9.01 | 8.36 | 9.00 | 876,176 | |
| 12/05/2024 | 8.95 | 9.10 | 8.47 | 8.50 | 777,586 | |
| 12/04/2024 | 8.75 | 9.03 | 8.70 | 8.95 | 480,116 | |
| 12/03/2024 | 8.68 | 9.18 | 8.60 | 8.84 | 909,184 | |
| 12/02/2024 | 8.79 | 8.91 | 8.51 | 8.71 | 1,110,736 | |
| 11/29/2024 | 8.90 | 9.01 | 8.61 | 8.87 | 423,267 | |
| 11/27/2024 | 8.96 | 9.11 | 8.78 | 8.97 | 669,600 | |
| 11/26/2024 | 9.07 | 9.14 | 8.66 | 8.97 | 955,289 | |
| 11/25/2024 | 9.45 | 9.57 | 8.76 | 9.09 | 1,336,035 | |
| 11/22/2024 | 9.02 | 9.98 | 8.95 | 9.34 | 1,224,810 | |
| 11/21/2024 | 8.67 | 9.62 | 8.61 | 9.45 | 1,097,408 | |
| 11/20/2024 | 9.38 | 9.59 | 8.55 | 8.73 | 1,352,700 | |
| 11/19/2024 | 8.78 | 9.48 | 8.64 | 9.37 | 1,835,668 | |
| 11/18/2024 | 8.78 | 9.10 | 8.49 | 8.89 | 1,214,502 | |
| 11/15/2024 | 9.13 | 9.30 | 8.54 | 8.78 | 2,157,181 | |
| 11/14/2024 | 9.70 | 9.77 | 8.98 | 9.09 | 1,481,799 | |
| 11/13/2024 | 9.63 | 10.10 | 8.91 | 9.75 | 3,402,950 | |
| 11/12/2024 | 13.12 | 13.32 | 9.24 | 9.52 | 10,386,131 | |
| 11/11/2024 | 17.07 | 17.63 | 12.95 | 13.10 | 4,553,124 | |
| 11/08/2024 | 18.95 | 19.05 | 16.79 | 16.86 | 1,260,418 | |
| 11/07/2024 | 18.78 | 18.80 | 16.52 | 18.50 | 1,358,855 | |
| 11/06/2024 | 18.98 | 19.05 | 17.94 | 18.00 | 976,297 | |
| 11/05/2024 | 18.98 | 19.05 | 17.90 | 18.37 | 652,705 | |
| 11/04/2024 | 18.00 | 19.50 | 17.80 | 18.94 | 1,174,949 | |
| 11/01/2024 | 17.39 | 18.62 | 16.87 | 18.27 | 1,093,662 | |
| 10/31/2024 | 17.41 | 17.42 | 16.77 | 17.15 | 689,946 | |
| 10/30/2024 | 17.09 | 17.88 | 16.76 | 17.42 | 323,416 | |
| 10/29/2024 | 17.51 | 17.75 | 16.94 | 17.28 | 872,881 | |
| 10/28/2024 | 16.32 | 17.58 | 16.20 | 17.38 | 1,422,176 | |
| 10/25/2024 | 16.29 | 16.57 | 15.60 | 16.05 | 1,114,867 | |
| 10/24/2024 | 16.38 | 16.62 | 15.84 | 16.21 | 1,145,644 | |
| 10/23/2024 | 16.56 | 16.69 | 15.91 | 16.33 | 1,091,915 |
About Phathom Pharmaceuticals Stock history
Phathom Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Phathom is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Phathom Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Phathom Pharmaceuticals stock prices may prove useful in developing a viable investing in Phathom Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 59 M | 35.6 M | |
| Net Loss | -178 M | -186.8 M |
Phathom Pharmaceuticals Quarterly Net Working Capital |
|
Phathom Pharmaceuticals Stock Technical Analysis
Phathom Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Phathom Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Phathom Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Phathom Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Phathom to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.01) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | (4.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.